Delivery Order SPE2DB20D1100-SPE2DB24FA7A9
Award Date 3/13/24
Potential Completion Date 3/14/24
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $10,917.12 to provide CATHFLO ACTIVASE 2 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that runs through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $28,627.71 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CATHFLO ACTIVASE 2 MG VIALS. The contract has a completion date of May 10, 2022 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,429.76 for Cathflo Activase 2 mg vials on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,954,863 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $5,140.33 and a performance period through March 14, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $6,506.90 and a period of performance through April 3, 2024. This award is a task order under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $4,666.30 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide CATHFLO ACTIVASE 2 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the Corporate Office division of the parent company AmerisourceBergen Corporation. The $1,463.94 contract is for the provision of Cathflo Activase 2 mg vials, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order is issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp that has a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,070.90 order is for 2 milligram vials of Cathflo Activase, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $18,377.82 for Cathflo Activase 2 mg vials, with a completion date of August 13, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used in medical settings. This firm fixed-price delivery order, valued at $5,429.76, is scheduled for completion by August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...